Literature DB >> 27761612

Dynamic contrast-enhanced MRI for automatic detection of foci of residual or recurrent disease after prostatectomy.

N Andres Parra1, Amber Orman1, Kyle Padgett1,2, Victor Casillas2, Sanoj Punnen3, Matthew Abramowitz1, Alan Pollack1, Radka Stoyanova4.   

Abstract

PURPOSE: This study aimed to develop an automated procedure for identifying suspicious foci of residual/recurrent disease in the prostate bed using dynamic contrast-enhanced-MRI (DCE-MRI) in prostate cancer patients after prostatectomy.
MATERIALS AND METHODS: Data of 22 patients presenting for salvage radiotherapy (RT) with an identified gross tumor volume (GTV) in the prostate bed were analyzed retrospectively. An unsupervised pattern recognition method was used to analyze DCE-MRI curves from the prostate bed. Data were represented as a product of a number of signal-vs.-time patterns and their weights. The temporal pattern, characterized by fast wash-in and gradual wash-out, was considered the "tumor" pattern. The corresponding weights were thresholded based on the number (1, 1.5, 2, 2.5) of standard deviations away from the mean, denoted as DCE1.0, …, DCE2.5, and displayed on the T2-weighted MRI. The resultant four volumes were compared with the GTV and maximum pre-RT prostate-specific antigen (PSA) level. Pharmacokinetic modeling was also carried out.
RESULTS: Principal component analysis determined 2-4 significant patterns in patients' DCE-MRI. Analysis and display of the identified suspicious foci was performed in commercial software (MIM Corporation, Cleveland, OH, USA). In general, DCE1.0/DCE1.5 highlighted larger areas than GTV. DCE2.0 and GTV were significantly correlated (r = 0.60, p < 0.05). DCE2.0/DCA2.5 were also significantly correlated with PSA (r = 0.52, 0.67, p < 0.05). Ktrans for DCE2.5 was statistically higher than the GTV's Ktrans (p < 0.05), indicating that the automatic volume better captures areas of malignancy.
CONCLUSION: A software tool was developed for identification and visualization of the suspicious foci in DCE-MRI from post-prostatectomy patients and was integrated into the treatment planning system.

Entities:  

Keywords:  Dynamic contrast enhanced (DCE-)MRI; Pattern recognition, automated; Prostate bed; Prostate cancer; Salvage radiotherapy

Mesh:

Substances:

Year:  2016        PMID: 27761612      PMCID: PMC5559220          DOI: 10.1007/s00066-016-1055-z

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  26 in total

1.  Nonnegative matrix factorization for rapid recovery of constituent spectra in magnetic resonance chemical shift imaging of the brain.

Authors:  Paul Sajda; Shuyan Du; Truman R Brown; Radka Stoyanova; Dikoma C Shungu; Xiangling Mao; Lucas C Parra
Journal:  IEEE Trans Med Imaging       Date:  2004-12       Impact factor: 10.048

2.  Endorectal magnetic resonance imaging at 1.5 Tesla to assess local recurrence following radical prostatectomy using T2-weighted and contrast-enhanced imaging.

Authors:  Stefano Cirillo; Massimo Petracchini; Lorenza Scotti; Teresa Gallo; Annalisa Macera; Maria Cristina Bona; Cinzia Ortega; Pietro Gabriele; Daniele Regge
Journal:  Eur Radiol       Date:  2008-09-30       Impact factor: 5.315

Review 3.  Modeling tracer kinetics in dynamic Gd-DTPA MR imaging.

Authors:  P S Tofts
Journal:  J Magn Reson Imaging       Date:  1997 Jan-Feb       Impact factor: 4.813

4.  Magnetic resonance imaging in postprostatectomy radiotherapy planning.

Authors:  Jana Sefrova; Karel Odrazka; Petr Paluska; Zdenek Belobradek; Milos Brodak; Martin Dolezel; Petr Prosvic; Zuzana Macingova; Milan Vosmik; Petr Hoffmann; Miroslav Louda; Anna Nejedla
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-03-21       Impact factor: 7.038

5.  Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy.

Authors:  Stephen J Freedland; Elizabeth B Humphreys; Leslie A Mangold; Mario Eisenberger; Frederick J Dorey; Patrick C Walsh; Alan W Partin
Journal:  JAMA       Date:  2005-07-27       Impact factor: 56.272

6.  Comparison of MRI with CT for the radiotherapy planning of prostate cancer: a feasibility study.

Authors:  V S Khoo; A R Padhani; S F Tanner; D J Finnigan; M O Leach; D P Dearnaley
Journal:  Br J Radiol       Date:  1999-06       Impact factor: 3.039

7.  Mapping Tumor Hypoxia In Vivo Using Pattern Recognition of Dynamic Contrast-enhanced MRI Data.

Authors:  Radka Stoyanova; Kris Huang; Kiri Sandler; Hyungjoon Cho; Sean Carlin; Pat B Zanzonico; Jason A Koutcher; Ellen Ackerstaff
Journal:  Transl Oncol       Date:  2012-12-01       Impact factor: 4.243

8.  Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy.

Authors:  Bruce J Trock; Misop Han; Stephen J Freedland; Elizabeth B Humphreys; Theodore L DeWeese; Alan W Partin; Patrick C Walsh
Journal:  JAMA       Date:  2008-06-18       Impact factor: 56.272

Review 9.  Choline PET or PET/CT and biochemical relapse of prostate cancer: a systematic review and meta-analysis.

Authors:  Laura Evangelista; Fabio Zattoni; Andrea Guttilla; Giorgio Saladini; Filiberto Zattoni; Patrick M Colletti; Domenico Rubello
Journal:  Clin Nucl Med       Date:  2013-05       Impact factor: 7.794

Review 10.  Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols.

Authors:  P S Tofts; G Brix; D L Buckley; J L Evelhoch; E Henderson; M V Knopp; H B Larsson; T Y Lee; N A Mayr; G J Parker; R E Port; J Taylor; R M Weisskoff
Journal:  J Magn Reson Imaging       Date:  1999-09       Impact factor: 4.813

View more
  3 in total

Review 1.  The role of MRI in prostate cancer: current and future directions.

Authors:  Maria Clara Fernandes; Onur Yildirim; Sungmin Woo; Hebert Alberto Vargas; Hedvig Hricak
Journal:  MAGMA       Date:  2022-03-16       Impact factor: 2.533

2.  Automatic Detection and Quantitative DCE-MRI Scoring of Prostate Cancer Aggressiveness.

Authors:  Nestor Andres Parra; Alan Pollack; Felix M Chinea; Matthew C Abramowitz; Brian Marples; Felipe Munera; Rosa Castillo; Oleksandr N Kryvenko; Sanoj Punnen; Radka Stoyanova
Journal:  Front Oncol       Date:  2017-11-10       Impact factor: 6.244

3.  Worth a local treatment? - Analysis of modern radiotherapy concepts for oligometastatic prostate cancer.

Authors:  M Oertel; S Scobioala; K Kroeger; A Baehr; L Stegger; U Haverkamp; M Schäfers; H-T Eich
Journal:  Radiat Oncol       Date:  2018-09-21       Impact factor: 3.481

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.